Search
Kestra Medical Technologies Ltd
KMTSAdd to Watchlist
28.800USD
+0.270+0.95%
Close 11-06 16:00（ET）
1.72BMarket Cap
LossP/E TTM
Kestra Medical Technologies Ltd (KMTS) Stock Price Target & Forecast
Analyst Rating
Based on 8 analysts giving stock ratings to Kestra Medical Technologies Ltd in the past month.
Buy
4 Strong Buy
3 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
30.857USD+3.93%
KMTS Analyst Recommendation Trends
In the current month, KMTS has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. KMTS average Analyst price target in the last month is 30.857.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
4
4
4
4
4
4
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
7
7
7
7
7
7
KMTS Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Boston Scientific Corp
BSX
7
15
11
0
0
33
Edwards Lifesciences Corp
EW
10
14
6
0
0
30
Thermo Fisher Scientific Inc
TMO
10
17
3
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
Agilent Technologies Inc
A
6
11
7
0
0
24
Resmed Inc
RMD
3
8
10
1
1
23
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Financial Forecasting
Based on analysts' estimates, KMTS EPS is projected to reach -0.604 in FY2027Q2, following reported EPS of -0.753 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
Forecast
-0.60
-0.60
-0.62
-0.60
-0.58
Actual
-0.61
-0.67
-0.75
--
--
Surprise
-2.69%
-11.99%
-22.23%
--
--
FAQs
What is Kestra Medical Technologies Ltd's expected revenue for the next quarter?
Kestra Medical Technologies Ltd's expected revenue is 32.09M.
What is Kestra Medical Technologies Ltd's price target?
Analysts forecast that Kestra Medical Technologies Ltd's price target is USD 30.86, with the highest forecast at USD 34.00 and the lowest forecast at USD 28.00.
How have Kestra Medical Technologies LtdKMTS's recent earnings per share performed?
The market expectation was USD -0.75, while Kestra Medical Technologies LtdKMTS's earnings per share (EPS) for the previous quarter was USD -0.67. EPS for the next quarter is expected at USD -0.60.
What is the analyst rating for Kestra Medical Technologies Ltd?
Based on the ratings of Kestra Medical Technologies Ltd's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.